INTS
Intensity Therapeutics, Inc. Common stockstockNASDAQ
At CloseNov 18, 2026 1:27:05 PM EST
2.57USD-3.745%(-0.10)21,057
After-hoursNov 18, 2026 4:42:30 PM EST
2.5148USD-2.148%(-0.0552)
Loading…
Loading…
9.01M
Healthcare
Biotechnology
HQ
Westport, CT, USA
Previous Close
$2.67
Beta
1.31
52-Week High
$15.00 2025-12-12
52-Week Low
$2.53 2026-11-18
SMA 50
$3.46
SMA 200
$4.79
Avg. Vol 10D
22,263
Avg. Vol 30D
19,757
Avg. Vol 90D
23,418
Relative Vol
1.07
3.30M
1.46M
44.11%
75,853
5.21%
7.24
37%/63%
73.31%
54.96%
5.7100%
200,000
32
1,008
3,584
Feb 19, 2026 · 1-for-25 (reverse)
-12.0M
-161.84
Nov 7, 2026
Nov 6, 2026
Nov 5, 2026
Intensity (INTS) Q3 2026 Earnings Call Transcript ·
The Motley Fool+1 source
Intensity Therapeutics reports Q3 results ·
Seeking Alpha
INTS Profile
intensity therapeutics is a connecticut based biopharmaceutical company whose mission is to create safer and more efficacious chemotherapy treatments. intensity therapeutics is a preclinical, in vivo stage company seeking investors interested in helping to advance the company's technology and products.
INTS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.10 | 2026-11-12 | -11.94% | 0.494 |
| 1M | 3.29 | 2026-10-19 | -17.02% | 1.986 |
| 3M | 4.20 | 2026-08-19 | -35.00% | 1.382 |
| 6M | 4.59 | 2026-05-19 | -40.52% | 0.979 |
| 1Y | 10.69 | 2025-11-19 | -74.45% | 1.310 |
| 2Y | 75.00 | 2024-11-19 | -96.36% | — |
| 5Y | 149.00 | 2023-06-30 | -98.17% | -0.097 |
INTS Stock Summary
Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) stock price today is $2.73, and today's volume is 21,057. INTS is up 2.247% today. The 30 day average volume is 19,757. INTS market cap is $9.01M with 3.30M shares outstanding.